Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

133 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ductal carcinoma in situ of the male breast. Analysis of 31 cases.
Cutuli B, Dilhuydy JM, De Lafontan B, Berlie J, Lacroze M, Lesaunier F, Graic Y, Tortochaux J, Resbeut M, Lesimple T, Gamelin E, Campana F, Reme-Saumon M, Moncho-Bernier V, Cuilliere JC, Marchal C, De Gislain G, N'Guyen TD, Teissier E, Velten M. Cutuli B, et al. Among authors: lesimple t. Eur J Cancer. 1997 Jan;33(1):35-8. doi: 10.1016/s0959-8049(96)00436-4. Eur J Cancer. 1997. PMID: 9071896 Review.
Androgen receptor gene mutation in male breast cancer.
Lobaccaro JM, Lumbroso S, Belon C, Galtier-Dereure F, Bringer J, Lesimple T, Namer M, Cutuli BF, Pujol H, Sultan C. Lobaccaro JM, et al. Among authors: lesimple t. Hum Mol Genet. 1993 Nov;2(11):1799-802. doi: 10.1093/hmg/2.11.1799. Hum Mol Genet. 1993. PMID: 8281139
Multicentre, phase II study evaluating capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer.
Fumoleau P, Largillier R, Clippe C, Dièras V, Orfeuvre H, Lesimple T, Culine S, Audhuy B, Serin D, Curé H, Vuillemin E, Morère JF, Montestruc F, Mouri Z, Namer M. Fumoleau P, et al. Among authors: lesimple t. Eur J Cancer. 2004 Mar;40(4):536-42. doi: 10.1016/j.ejca.2003.11.007. Eur J Cancer. 2004. PMID: 14962720 Clinical Trial.
MBD4 deficiency is predictive of response to immune checkpoint inhibitors in metastatic uveal melanoma patients.
Saint-Ghislain M, Derrien AC, Geoffrois L, Gastaud L, Lesimple T, Negrier S, Penel N, Kurtz JE, Le Corre Y, Dutriaux C, Gardrat S, Barnhill R, Matet A, Cassoux N, Houy A, Ramtohul T, Servois V, Mariani P, Piperno-Neumann S, Stern MH, Rodrigues M. Saint-Ghislain M, et al. Among authors: lesimple t. Eur J Cancer. 2022 Sep;173:105-112. doi: 10.1016/j.ejca.2022.06.033. Epub 2022 Jul 19. Eur J Cancer. 2022. PMID: 35863105
Impact of radiotherapy administered simultaneously with systemic treatment in patients with melanoma brain metastases within MelBase, a French multicentric prospective cohort.
Tétu P, Allayous C, Oriano B, Dalle S, Mortier L, Leccia MT, Guillot B, Dalac S, Dutriaux C, Lacour JP, Saiag P, Brunet-Possenti F, De Quatrebarbes J, Stoebner PE, Legoupil D, Beylot-Barry M, Lesimple T, Aubin F, Dreno B, Mohamed S, Ballon A, Porcher R, Lebbe C. Tétu P, et al. Among authors: lesimple t. Eur J Cancer. 2019 May;112:38-46. doi: 10.1016/j.ejca.2019.02.009. Epub 2019 Mar 22. Eur J Cancer. 2019. PMID: 30909072
Cisplatin alone or combined with gemcitabine in carcinomas of unknown primary: results of the randomised GEFCAPI 02 trial.
Gross-Goupil M, Fourcade A, Blot E, Penel N, Négrier S, Culine S, Chaigneau L, Lesimple T, Priou F, Lortholary A, Kaminsky MC, Provencal J, Voog E, Bouzy J, Laplanche A, Fizazi K. Gross-Goupil M, et al. Among authors: lesimple t. Eur J Cancer. 2012 Mar;48(5):721-7. doi: 10.1016/j.ejca.2012.01.011. Epub 2012 Feb 6. Eur J Cancer. 2012. PMID: 22317952 Review.
An open label, non-randomised, phase IIIb study of trametinib in combination with dabrafenib in patients with unresectable (stage III) or distant metastatic (stage IV) BRAF V600-mutant melanoma: A subgroup analysis of patients with brain metastases.
Dutriaux C, Robert C, Grob JJ, Mortier L, Dereure O, Lebbe C, Mansard S, Grange F, Neidhardt EM, Lesimple T, Machet L, Bedane C, Maillard H, Dalac-Rat S, Nardin C, Szenik A, Denden A, Saiag P. Dutriaux C, et al. Among authors: lesimple t. Eur J Cancer. 2022 Nov;175:254-262. doi: 10.1016/j.ejca.2022.07.035. Epub 2022 Sep 25. Eur J Cancer. 2022. PMID: 36170791 Free article. Clinical Trial.
Merkel cell carcinoma: value of sentinel lymph-node status and adjuvant radiation therapy.
Servy A, Maubec E, Sugier PE, Grange F, Mansard S, Lesimple T, Marinho E, Couturaud B, Girod A, Albert S, Dendale R, Calitchi E, Sarda L, Chanal J, Deschamps L, Sastre-Garau X, Laroche L, Crickx B, Avril MF. Servy A, et al. Among authors: lesimple t. Ann Oncol. 2016 May;27(5):914-9. doi: 10.1093/annonc/mdw035. Epub 2016 Jan 24. Ann Oncol. 2016. PMID: 26811346 Free article.
Efficacy, safety and factors associated with disease progression in patients with unresectable (stage III) or distant metastatic (stage IV) BRAF V600-mutant melanoma: An open label, non-randomized, phase IIIb study of trametinib in combination with dabrafenib.
Saiag P, Robert C, Grob JJ, Mortier L, Dereure O, Lebbe C, Mansard S, Grange F, Neidhardt EM, Lesimple T, Machet L, Bedane C, Maillard H, Dalac-Rat S, Nardin C, Szenik A, Denden A, Dutriaux C. Saiag P, et al. Among authors: lesimple t. Eur J Cancer. 2021 Sep;154:57-65. doi: 10.1016/j.ejca.2021.05.031. Epub 2021 Jul 6. Eur J Cancer. 2021. PMID: 34243078 Free article. Clinical Trial.
133 results